Skip to content
Trial Eligibility
Menu

Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section

NCT06297499

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Opioids are often added with a local anesthetic to enhance the duration and quality of spinal anesthesia for cesarean delivery patients. However, spinal opioids are associated with a wide variety of side effects such as nausea, vomiting, (N/V) and pruritus (itching). The occurrence of pruritus can vary between 30% and 100% making pruritus the most common side-effect of intrathecal opioids and this rate is even higher in pregnant patients. Pruritus may require treatment which can be ineffective or sometimes reverse the analgesic effect of the opioids.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Pruritus Caused by Drug

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 to 50 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
Wayne State University
Last updated on ClinicalTrials.gov
March 28, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Michigan · 1

  • Detroit Medical Center- Hutzel Women's Hospital · Detroit, MI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.